Omentin plasma levels and gene expression are decreased in obesity |
| |
Authors: | de Souza Batista Celia M Yang Rong-Ze Lee Mi-Jeong Glynn Nicole M Yu Dao-Zhan Pray Jessica Ndubuizu Kelechi Patil Susheel Schwartz Alan Kligman Mark Fried Susan K Gong Da-Wei Shuldiner Alan R Pollin Toni I McLenithan John C |
| |
Institution: | Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA. |
| |
Abstract: | Central obesity and the accumulation of visceral fat are risk factors for the development of type 2 diabetes and cardiovascular disease. Omentin is a protein expressed and secreted from visceral but not subcutaneous adipose tissue that increases insulin sensitivity in human adipocytes. To determine the impact of obesity-dependent insulin resistance on the regulation of two omentin isoforms, gene expression and plasma levels were measured in lean, overweight, and obese subjects. Omentin 1 was shown to be the major circulating isoform in human plasma. Lean subjects had significantly higher plasma omentin 1 levels than obese and overweight subjects. In addition, higher plasma omentin 1 levels were detected in women compared with men. Plasma omentin 1 levels were inversely correlated with BMI, waist circumference, leptin levels, and insulin resistance as measured by homeostasis model assessment and positively correlated with adiponectin and HDL levels. Both omentin 1 and omentin 2 gene expression were decreased with obesity and were highly correlated with each other in visceral adipose tissue. In summary, decreased omentin levels are associated with increasing obesity and insulin resistance. Therefore, omentin levels may be predictive of the metabolic consequences or co-morbidities associated with obesity. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|